Cape Ann Savings Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $250K | Sell |
10,378
-450
| -4% | -$11.8K | 0.12% | 105 |
|
|
2026
Q1 | $304K | Sell |
10,828
-856
| -7% | -$22.8K | 0.15% | 92 |
|
|
2025
Q4 | $291K | Sell |
11,684
-550
| -4% | -$13.9K | 0.15% | 91 |
|
|
2025
Q3 | $312K | Hold |
12,234
| – | – | 0.17% | 84 |
|
|
2025
Q2 | $297K | Sell |
12,234
-215
| -2% | -$5.01K | 0.18% | 76 |
|
|
2025
Q1 | $315K | Sell |
12,449
-425
| -3% | -$11.1K | 0.2% | 70 |
|
|
2024
Q4 | $342K | Sell |
12,874
-3,025
| -19% | -$82.1K | 0.2% | 66 |
|
|
2024
Q3 | $460K | Hold |
15,899
| – | – | 0.27% | 59 |
|
|
2024
Q2 | $445K | Hold |
15,899
| – | – | 0.28% | 61 |
|
|
2024
Q1 | $441K | Sell |
15,899
-542
| -3% | -$15K | 0.28% | 61 |
|
|
2023
Q4 | $445K | Sell |
16,441
-850
| -5% | -$25.7K | 0.29% | 59 |
|
|
2023
Q3 | $574K | Sell |
17,291
-560
| -3% | -$19.8K | 0.4% | 54 |
|
|
2023
Q2 | $655K | Buy |
17,851
+802
| +5% | +$31.2K | 0.44% | 50 |
|
|
2023
Q1 | $696K | Buy |
17,049
+210
| +1% | +$9.07K | 0.49% | 48 |
|
|
2022
Q4 | $863K | Sell |
16,839
-273
| -2% | -$13.1K | 0.63% | 40 |
|
|
2022
Q3 | $749K | Sell |
17,112
-115
| -0.7% | -$5.59K | 0.6% | 43 |
|
|
2022
Q2 | $903K | Sell |
17,227
-31
| -0.2% | -$1.58K | 0.69% | 36 |
|
|
2022
Q1 | $893K | Sell |
17,258
-1,859
| -10% | -$96.5K | 0.59% | 42 |
|
|
2021
Q4 | $1.13M | Sell |
19,117
-939
| -5% | -$46.5K | 0.68% | 37 |
|
|
2021
Q3 | $863K | Sell |
20,056
-291
| -1% | -$12.9K | 0.56% | 43 |
|
|
2021
Q2 | $797K | Sell |
20,347
-96
| -0.5% | -$3.73K | 0.5% | 47 |
|
|
2021
Q1 | $741K | Sell |
20,443
-835
| -4% | -$29.6K | 0.53% | 50 |
|
|
2020
Q4 | $783K | Buy |
+21,278
| New | +$780K | 0.57% | 44 |
|
|
2020
Q2 | $828K | Buy |
+26,678
| New | +$906K | 0.7% | 40 |
|
|
2019
Q3 | $792K | Sell |
23,255
-8,622
| -27% | -$314K | 0.91% | 31 |
|
|
2019
Q2 | $1.31M | Sell |
31,877
-274
| -0.9% | -$10.9K | 1.51% | 20 |
|
|
2019
Q1 | $1.3M | Hold |
32,151
| – | – | 1.54% | 23 |
|
|
2018
Q4 | $1.28M | Sell |
32,151
-1,660
| -5% | -$68.9K | 1.56% | 23 |
|
|
2018
Q3 | $1.41M | Buy |
33,811
+184
| +0.5% | +$7.08K | 1.67% | 21 |
|
|
2018
Q2 | $1.19M | Buy |
+33,627
| New | +$1.15M | 1.48% | 22 |
|
|
2017
Q4 | $1.13M | Buy |
+32,799
| New | +$1.12M | 1.42% | 23 |
|
|
2017
Q2 | $1.08M | Hold |
34,038
| – | – | 1.44% | 24 |
|
|
2017
Q1 | $1.1M | Buy |
34,038
+316
| +0.9% | +$9.96K | 1.49% | 22 |
|
|
2016
Q4 | $1.02M | Sell |
33,722
-346
| -1% | -$10.6K | 1.43% | 24 |
|
|
2016
Q3 | $1.09M | Sell |
34,068
-1,037
| -3% | -$34.7K | 1.54% | 21 |
|
|
2016
Q2 | $1.17M | Sell |
35,105
-304
| -0.9% | -$9.7K | 1.61% | 19 |
|
|
2016
Q1 | $996K | Sell |
35,409
-158
| -0.4% | -$4.51K | 1.37% | 22 |
|
|
2015
Q4 | $1.09M | Buy |
35,567
+316
| +0.9% | +$9.94K | 1.49% | 22 |
|
|
2015
Q3 | $1.05M | Buy |
35,251
+859
| +2% | +$27.5K | 1.56% | 20 |
|
|
2015
Q2 | $1.09M | Sell |
34,392
-327
| -0.9% | -$10.7K | 1.55% | 21 |
|
|
2015
Q1 | $1.15M | Sell |
34,719
-158
| -0.5% | -$5.02K | 1.6% | 20 |
|
|
2014
Q4 | $1.03M | Sell |
34,877
-746
| -2% | -$21.4K | 1.48% | 24 |
|
|
2014
Q3 | $999K | Buy |
35,623
+1,107
| +3% | +$31.1K | 1.48% | 25 |
|
|
2014
Q2 | $972K | Buy |
34,516
+4,616
| +15% | +$132K | 1.41% | 27 |
|
|
2014
Q1 | $911K | Sell |
29,900
-421
| -1% | -$12.6K | 1.5% | 24 |
|
|
2013
Q4 | $881K | Sell |
30,321
-596
| -2% | -$17.3K | 1.42% | 24 |
|
|
2013
Q3 | $843K | Sell |
30,917
-1,739
| -5% | -$47.3K | 1.44% | 24 |
|
|
2013
Q2 | $868K | Buy |
+32,656
| New | +$902K | 1.45% | 26 |
|
Other funds holding PFE
Cape Ann Savings Bank's PFE Position: Q2 2026 in Review
Cape Ann Savings Bank reduced its Pfizer (PFE) stake by 4.2% in Q2 2026, selling an estimated $11.8K and leaving 10,378 shares worth $250K. The position accounts for 0.12% of the portfolio, ranked #105.
Cape Ann Savings Bank first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.41M in Q3 2018. 1,698 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cape Ann Savings Bank held 10,378 shares of Pfizer worth $250K as of Q2 2026.
- Cape Ann Savings Bank sold 450 Pfizer shares in Q2 2026, an estimated $11.8K.
- Pfizer made up 0.12% of Cape Ann Savings Bank's portfolio in Q2 2026, its #105 holding.
- Cape Ann Savings Bank first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
- Cape Ann Savings Bank's Pfizer position peaked at $1.41M in Q3 2018.
- 1,698 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cape Ann Savings Bank's 13F filing for Q2 2026, filed 4 Aug 2026.